Document is current

Any future updates will be listed below

Successful treatment of refractory erythrodermic pemphigus foliaceus with low-dose rituximab and intravenous immunoglobulin

Crossref DOI link: https://doi.org/10.1007/s00011-025-02059-8

Published Online: 2025-06-03

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark